Latest Press Release on Pharmaceutical

BioSante Pharmaceuticals Comments on Boehringer Ingelheim Clinical Test Results in Treatment of Female Sexual Dysfunction
LINCOLNSHIRE, Ill. - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim t

---

EntreMed's ENMD-2076 Active in Solid and Hematological Cancers
ROCKVILLE, Md., Nov. 16 -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of data for the Phase 1 study for its Aurora A/angiogenic kinase inhibitor, E...

---

ScinoPharm Announces SafeBridge Potent Compound Safety Certification
TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc. T...

---

La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
SAN DIEGO - La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the “Company”) today announced that its Special Meeting of Stockholders, which was originally convened on October 30, 2009 and reconvened on November 6, 2009 and November 13, 2009, was adjourned to November

---

China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference
HAIKOU CITY, China, Nov. 17 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China

---

Dragon Pharma Reports 2009 Third Quarter Financial Results
VANCOUVER, BRITISH COLUMBIA -- 11/16/09 -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced its financial results for the third quarter..

---

PCMA: Butterfield Bill Would Increase Pharmacy Costs, Undermine Unions and Employers
WASHINGTON - The Pharmaceutical Care Management Association (PCMA) issued the following statement regarding the introduction of the “Patient Health & Real Medication Access Cost Savings Act of 2009,” by Representative G.K. Butterfield (D – NC):

---

Omnicare Declares Quarterly Cash Dividend
COVINGTON, Ky. - The Board of Directors of Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, declared today a quarterly cash dividend of 2.25 cents ($0.0225) per share on its common stock. The dividend is payable December 21, 2009 to stockholders of record

---

Spherix Announces the Closing of $6.3 Million Registered Direct Offering
BETHESDA, Md., Nov. 19 -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced...

---

Spherix Announces Results of Annual Shareholders Meeting
BETHESDA, Md., Nov. 19 -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced the resul...

---

Acurian Announces Licensing Agreement with i3 for Clinical Research Site Selection Services
HORSHAM, Pa. - Acurian, Inc., a leading, full-service provider of patient recruitment and retention solutions, announced today that it entered into an agreement with pharmaceutical services company i3 to offer improved site identification and selection to its customers. Through the agreement

---

Pharmaceutical Companies Don't Expect Industry Increase With Health Care Reform
WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industr...

---

NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009
FLEMINGTON, N.J. - NovaDel Pharma Inc. (the “Company”) (NYSE AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its third quarter and nine months ended September 30, 2009. For

---

Emetrol(R) Sponsors WebMD Tips on Treating Nausea for Moms During 2009-2010 Flu Season
SARASOTA, Fla., Nov. 19 /PRNewswire/ -- WellSpring Pharmaceutical Corporation is sponsoring a multi-part, WebMD section for mothers with advice about treating nausea and vomiting during the flu season. "Nausea & Vomiting: A Mom's Guide for the Family" (

---

Reflect Scientific Enters Cooperative Agreement With Resonon
OREM, UT -- 11/19/09 -- Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, medical, industrial and transportation industries, announced the Company has entered into a collabora..

---

US panel backs Pfizer’s new vacine. Reported by Chartpoppers.com
(EMAILWIRE.COM, November 19, 2009 ) Point Roberts, WA - Chartpoppers.com announces an investment report featuring company Pfizer Inc. (NYSE:PFE)Pfizer Inc. is a research-based, global pharmaceutical company. The Company discovers, develops, manufact..

---

A.P. Pharma Reports Third Quarter 2009 Financial Results
REDWOOD CITY, Calif. - A.P. Pharma, Inc. (Nasdaq: APPA), a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2009. Results of Operations A.P. Pharma’s net loss for the third quarter

---

Shengtai Pharmaceutical Schedules Fiscal Year 2010 First Quarter Financial Results and Conference Call
WEIFANG, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose produc...

---

Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated
NEW YORK, Nov. 16 /PRNewswire/ -- Personalized Pharmaceutical Systems (PPS) today announced the sale of the Angioedema Clinical Prediction Guide to Viropharma Incorporated. PPS is a clinical trial enrichment and market differentiation company which has developed advanced...

---

Putney Secures $6.7M in Series B Funding, Prepares to Double Revenue and R&D Pipeline
PORTLAND, Maine, Nov. 16 /PRNewswire/ -- Putney, Inc., a rapidly growing pet pharmaceutical company, has closed a $6.7M Series B funding round. The round was led by strategic investor Peter Werth as well as financial investors including a Pritzker family trust. Series A investors were also ...

---

Derma Sciences Files S-1 Registration Statement
PRINCETON, N.J., Nov. 16 -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI) a specialty medical device/pharmaceutical company focused on advanced wound care, announced today that it has filed an S-1 Registration Statement to offer 1,500,000 shares of i...

---

American Oriental Bioengineering Reports Third Quarter 2009 Financial Results
NEW YORK, Nov. 16 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commerciali...

---

Spherix Incorporated To Raise $6.3 Million In Registered Direct Offering
BETHESDA, Md., Nov. 16 -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it h...

---

Brookstone Pharmaceuticals, LLC becomes Acella Pharmaceuticals, LLC
ALPHARETTA, Ga., Nov. 16 /PRNewswire/ -- Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more ac...

---

Xanodyne Announces FDA Approval of Lysteda(TM) (Tranexamic Acid) for Treatment of Women with Heavy Menstrual Bleeding
NEWPORT, Ky., Nov. 16 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral t...

---